Keywords: cambridge, neuroscience, gains, fda, approval, received, food

CAMBRIDGE NEUROSCIENCE GAINS FDA APPROVAL

Article | 01 March 1993

- Cambridge Neuroscience has received approval from the US Food and Drug Administration to begin Phase I trials of Cerestat for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in